A groundbreaking shift in our drug policy has taken place, as the regulators allow the use of psilocybin hallucinogens for therapeutic treatment. Previously, these substances were strictly restricted, but a mounting body of studies suggests they potentially offer relief for emotional issues like PTSD. This change represents a key step toward rethin